[Oral lesions in systemic lupus erythematosus. II. The clinical and therapeutic aspects of lupus erythematosus].
The authors describe the most common clinical characteristics and main parameters of SLE. They describe the currently most therapeutic protocol with particular reference to circulating immune complex study on patients with SLE, and they examine different prospects of applicability and of prognostic result. The aim of this paper is to provide an outline of the clinical diagnosis and the immunobiological significance of the nucleoprotein autoantibodies and of the Ro/SSA antigen-antibody system and the relationship between circulating anti Ro/SSa antibody levels and skin disease activity in SLE.
Bonaccorso
A
A
Corso di Laurea in Odontoiatria e Protesi Dentaria, Università degli Studi, Catania.
Tripi
T R
TR
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D003937:Diagnosis, Differential; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis* / Q000188:drug therapy; D009059:Mouth Diseases / Q000175:diagnosis* / Q000188:drug therapy
D000305:Adrenal Cortex Hormones
Lesioni orali nel lupus eritematoso sistemico. Nota II: Aspetti clinici e terapeutici del lupus eritematoso.